Program Northern Lights on Colorectal Diseases

Immunotherapy in CRC (d- and PMMR), Dr. Myriam Chalabi, Netherlands

ctDNA in Colorectal Cancer, Prof. Jeanne Tie, Australia

IBD-assoiated dysplasia – when to operate, Prof. Ailsa Hart, United Kingdom

Mechanisms of action of aspirin, Prof. Ruth Langley, United Kingdom

Beyond TME 1948-2048, Dr. Ian Jenkins, United Kingdom

Induction vc Consolidation - Chemotherapy in TNT for Rectal Cancer
Prof. Emmanouil Fokas, Germany vs. Dr. Alice Couwenberg, Netherlands

Minimally Invasive Surgery for beyond-TME: Yes or No
Dr. Ebbe Billmann Thorgersen, Norway vs. Ass Prof. Cherry Koh, Australia

IPAA in rectal cancer: Yes or No
Prof. Antonino Spinelli, Italy vs. Prof. Pieter Tanis, Netherlands

Direct sugery in Crohn
Dr. Christianne Buskens, Netherlands vs Prof. Ailsa Hart, United Kingdom

The role of Exclusive Enteral Nutrition in colorectal surgery
Dr. Rotem Sigall Boneh, Israel

Prehabilitation – the evidence?
Ass Prof. Ulf Gustafsson, Sweden

When NoLap is the optimal procedure
Prof. Jugdeep Dhesi, United Kingdom

The Vasa Museum

The Optimal colorectal anastomosis, Prof. Antonini Spinelli, Italy

Failed despite optimal – can we salvage?, Prof. Pieter Tanis, Netherlands

The optimal anastomosis in Crohn´s disease, Dr. Christianne Buskens, Netherlands
 

STAR-TReC trial
Prof. Simon Bach, United Kingdom vs. Prof. Quentin Denost, France

IDEAL trial
Prof. Laura Beyer Berjot, France vs. Dr. Christianne Buskens, Netherlands

Challenge trial
Prof. Sharlene Gill, Canada vs Prof. Olof Akre, Sweden

Locally recurrent CRC – where's the limit?, Ass Prof. Cherry Koh, Australia

Intestinal Failure – where's the limit medically?, Prof. Simon Lal, United Kingdom

Intestinal Failure – where is the surgical limit?, Prof. Gordon Carlson, USA

T2 Rectal Cancer - TME is optimal, Prof. André D'Hoore, Belgium

T2 Rectal Cancer - Local excision does the trick, Prof. Quentin Denost, France

T2 Rectal Cancer – Radiotherapy works perfectly, Prof. Simon Bach, United Kingdom